Sanofi Consumer Healthcare India has appointed M/s. Price Waterhouse & Co Chartered Accountants LLP (PwC) as its statutory auditor to fill the casual vacancy caused by the resignation of M/s. Kalyaniwalla & Mistry LLP. The Board of Directors approved the appointment at its meeting held on May 25, 2026, based on the recommendation of the Audit Committee. The new auditor will hold office until the conclusion of the company's ensuing Annual General Meeting (AGM), subject to shareholder approval.

Furthermore, the Board has approved the appointment of PwC as the statutory auditors for a term of five consecutive years. This term is set to commence from the conclusion of the ensuing AGM to be held in 2026 and will continue until the conclusion of the Eighth AGM to be held in 2031. This extension is also subject to the approval of the shareholders.

The appointment follows the resignation of the previous auditors, M/s. Kalyaniwalla & Mistry LLP, Chartered Accountants. The company communicated this development to the stock exchanges pursuant to Regulation 30 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Auditor Details

The following table outlines the key details regarding the appointment:

PwC, established in 1991 and converted into a limited liability partnership in 2014, is a firm of Chartered Accountants registered with the Institute of Chartered Accountants of India. The firm operates from its registered office in Kolkata and 17 branch offices across India. It is a member firm of Price Waterhouse & Affiliates and holds a valid peer review certificate, auditing various listed companies in India.

Sanofi Consumer Healthcare India Limited delivered impressive financial performance in Q1'26, demonstrating strong growth across multiple business segments. The company's Board of Directors approved the unaudited financial results for the quarter ended 31st March 2026 during their meeting held on 28th April 2026.

Official Regulatory Filing

The company announced its Q1'26 results through a press release filed under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 on 30th April 2026. The announcement was made to both BSE Limited (Scrip Code: 544250) and National Stock Exchange of India Limited (Symbol: SANOFICONR).

Financial Performance Overview

The company's financial metrics for Q1'26 showed robust year-on-year growth across key parameters:

Business Segment Performance

The company's domestic operations showed strong momentum with 15.5% growth in domestic sales. This growth was primarily driven by the successful relaunch of recalled products back to the market, indicating effective operational recovery and market response.

Export sales demonstrated exceptional performance with 144% growth, though the company attributed this significant increase to a low base effect from the previous year. This substantial export growth contributed meaningfully to the overall revenue performance for the quarter.

Management Commentary

Himanshu Bakshi, Managing Director of Sanofi Consumer Healthcare India Limited, highlighted the company's disciplined execution strategy. He emphasized that the domestic business outpaced market performance, delivering both market share gains and volume growth. Bakshi noted the company's commitment to simplifying self-care and making it more accessible and effective for consumers, guided by science and driven by purpose.

Company Background

Sanofi Consumer Healthcare India Limited operates as an independent entity following its demerger from Sanofi India Limited on 1st June 2024. The company focuses exclusively on the Consumer Healthcare sector with a portfolio spanning multiple therapeutic areas:

• Allergy Care • Digestive Wellness • Pain Care • Multivitamins

The company's key brands include Allegra®, DePURA®, Avil®, and Combiflam®. With its agile business model and strong brand portfolio, the company positions itself as one of the leading players in India's consumer healthcare market, leveraging global experience to enhance customer wellbeing through accessible self-care solutions.